Disease Biology

Measuring whole blood thrombin generation in patients with multiple myeloma

The impact of RBPs in the development of hematological malignancies and bone marrow failure

Approaching NK/T-cell lymphoma

Insights into the pathogenesis and treatment of autoimmune lymphoproliferative syndrome

Investigating the safety and efficacy of re-treating CLL patients with venetoclax-based regimens

The future of CLL treatment and more personalized approaches

The pathogenesis and treatment of Evans syndrome

The importance of family history in the diagnosis and management of hematological malignancies

The impact of ageing on myeloma disease biology

Molecular aberrations and epigenetic dysregulation in NK-LGL leukemia

Pathobiology & treatment of T-PLL

Types of histiocytosis and their treatment strategies

Prognostic value of CXCR4 mutations & thrombocytopenia in patients with WM treated with ibrutinib

Evaluating serum free light chain ratio as a biomarker for progression to multiple myeloma

The impact of SF3B1 mutations in myelofibrosis

The role of the immune microenvironment in PTLD